Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I–III pancreatic ductal adenocarcinoma: a retrospective cohort study

Yiping Zou(Tianjin Medical University Cancer Institute and Hospital), Jihui Hao(Tianjin Medical University Cancer Institute and Hospital), Tiansuo Zhao(Tianjin Medical University Cancer Institute and Hospital), Yongjie Xie(Tianjin Medical University Cancer Institute and Hospital), Xiuchao Wang(Jiangsu Province Hospital), Xiaofan Guo(Chinese University of Hong Kong), Antao Chang(Tianjin Medical University Cancer Institute and Hospital), Ran An(Case Western Reserve University), Xin Yu(Shanghai Clinical Research Center), Song Gao(Tianjin Medical University Cancer Institute and Hospital), Jun Yu(Johns Hopkins University), Tianxing Zhou(Tianjin Medical University Cancer Institute and Hospital), Chuntao Gao(Tianjin Medical University Cancer Institute and Hospital)
International Journal of Surgery
May 3, 2023
10.1097/js9.0000000000000425
Cited by 11

Related Papers

Midkine activation of CD8+ T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth
|Nature Communications|2020|170
Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
|Oncotarget|2014|141
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
|The Lancet|2023|139
Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression
|Nature Communications|2017|137
Paper-based microchip electrophoresis for point-of-care hemoglobin testing
|The Analyst|2020|71